Opinion
2011-1182 2011-1183 2011-1184 2011-1185 2011-1186 2011-1187 2011-1188 2011-1189 2011-1190
02-24-2012
ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, IPR PHARMACEUTICALS INC., and THE BRIGHAM AND WOMEN'S HOSPITAL, INC., Plaintiffs-Appellants, v. APOTEX CORP., Defendant-Appellee, and AUROBINDO PHARMA LIMITED, Defendant-Appellee, and COBALT PHARMACEUTICALS INC. and COBALT LABORATORIES INC., Defendants-Appellees, and GLENMARK GENERICS INC. USA, Defendant-Appellee, and MYLAN PHARMACEUTICALS INC., Defendant-Appellee, and PAR PHARMACEUTICALS, INC., Defendant-Appellee, and SUN PHARMACEUTICAL INDUSTRIES, LTD., Defendant-Appellee, and TEVA PHARMACEUTICALS USA, INC., Defendant-Appellee, and TORRENT PHARMA INC. and TORRENT PHARMACEUTICALS LTD., Defendants.
Shane A. Brunner , Mechant & Gould, P.C. of Madison, Wisconsin, argued for defendant-appellee "Aurobindo Pharma Limited" H. Ketto Sabharwal to "H. Keeto Sabharwal"
ERRATA
Precedential Opinion
Please make the following change: Page 3, correction of
Shane A. Brunner, Mechant & Gould, P.C. of Madison, Wisconsin, argued for defendant-appellee "Aurobindo Pharma Limited"
H. Ketto Sabharwal to "H. Keeto Sabharwal"